Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Lexeo Therapeutics, Inc. (LXEO) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-98.33M |
|
-- |
|
-- |
|
$105.77M |
|
$-105.77M |
|
$7.43M |
|
$-98.33M |
|
$-98.33M |
|
$-98.33M |
|
$-98.33M |
|
$-98.33M |
|
$-98.33M |
|
$-105.77M |
|
$-105.46M |
|
31.79M |
|
31.79M |
|
$-3.09 |
|
$-3.09 |
|
| Balance Sheet Financials | |
$126.12M |
|
$1.03M |
|
$20.82M |
|
$146.94M |
|
$22.85M |
|
$0.82M |
|
$7.25M |
|
$30.10M |
|
$116.84M |
|
$116.84M |
|
$116.84M |
|
33.07M |
|
| Cash Flow Statement Financials | |
$-81.15M |
|
$-94.08M |
|
$88.78M |
|
$124.72M |
|
$38.27M |
|
$-86.45M |
|
$12.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.52 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-84.16% |
|
-84.16% |
|
-66.92% |
|
-83.57% |
|
$3.53 |
|
$-2.57 |
|
$-2.55 |
|